Company · CIK 0001674416 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
CRISPR Therapeutics AG · CRSP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 5:35 pm EDT | James R. KasingerGeneral Counsel and Secretary | 10,400 | $60.24 | $626,460 | 94,784 | −9.89% | 10b5-1 |
| Sep 22, 2026 MForm 4 → | Sep 24, 5:35 pm EDT | James R. KasingerGeneral Counsel and Secretary | 10,400 | $13.62 | $141,648 | 105,184 | — | 10b5-1 |
| Sep 17, 2026 SForm 4 → | Sep 21, 6:40 pm EDT | Ali BehbahaniDirector | 13,679 | $57.09 | $780,935 | 16,637 | −45.1% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 6:40 pm EDT | Ali BehbahaniDirector | 30,000 | $14.00 | $420,000 | 30,316 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 24, 5:35 pm EDT | James R. KasingerGeneral Counsel and Secretary | 10,400 | — | — | 83,232 | — | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 21, 6:40 pm EDT | Ali BehbahaniDirector | 30,000 | — | — | 0 | — |